BIK (NBK) is a mediator of the sensitivity of Fanconi anaemia group C lymphoblastoid cell lines to interstrand DNA cross-linking agents

Biochemical Journal

Volumn 448, Issue 1, 2012, Pages 153-163

  Prieto Remón, Inés ^a   Sánchez Carrera, Dámaso ^a   López Duarte, Mónica ^a   Richard, Carlos ^a   Pipaón, Carlos ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Np73; Apoptosis; Bcl 2 interacting killer (BIK); Fanconi anaemia (FA); Interstrand DNA cross linking agents

Indexed keywords

BCL 2 INTERACTING KILLER PROTEIN; BH3 PROTEIN; FANCONI ANEMIA GROUP C PROTEIN; ISOPROTEIN; NP73 PROTEIN; PROTEIN P73; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL STRESS; CELL VIABILITY; CHEMOSENSITIZATION; CONTROLLED STUDY; DNA CROSS LINKING; EPIGENETICS; FANCONI ANEMIA; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENOTOXICITY; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; LYMPHOBLASTOID CELL LINE; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REGULATOR GENE; UPREGULATION;

5' UNTRANSLATED REGIONS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-2-ASSOCIATED X PROTEIN; CELL LINE; CELL LINE, TRANSFORMED; CISPLATIN; CROSS-LINKING REAGENTS; DNA; DNA DAMAGE; DNA METHYLATION; DNA-BINDING PROTEINS; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP C PROTEIN; GENES, REPORTER; HUMANS; LYMPHOCYTES; MEMBRANE PROTEINS; MITOMYCIN; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEINS;

EID: 84867791867     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20120327     Document Type: Article

References (39)

1. D'Andrea, A. D. (2010) Susceptibility pathways in Fanconi's anemia and breast cancer. N. Engl. J. Med. 362, 1909-1919
2. Rosenberg, P. S., Greene, M. H. and Alter, B. P. (2003) Cancer incidence in persons with Fanconi anemia. Blood 101, 822-826 (Pubitemid 36139345)
3. Valeri, A., Martínez, S., Casado, J. A. and Bueren, J. A. (2011) Fanconi anaemia: from a monogenic disease to sporadic cancer. Clin. Transl. Oncol. 13, 215-221
4. Río, P., Segovia, J. C., Hanenberg, H., Casado, J. A., Martínez, J., Göttsche, K., Cheng, N. C., Van de Vrugt, H. J., Arwert, F., Joenje, H. and Bueren, J. A. (2002) In vitro phenotypic correction of hematopoietic progenitors from Fanconi anemia group A knockout mice. Blood 100, 2032-2039 (Pubitemid 35001234)
5. Bijangi-Vishehsaraei, K., Saadatzadeh, M. R., Werne, A., McKenzie, K. A. W., Kapur, R., Ichijo, H. and Haneline, L. S. (2005) Enhanced TNF-α-induced apoptosis in Fanconi anemia type C-deficient cells is dependent on apoptosis signal-regulating kinase 1. Blood 106, 4124-4130 (Pubitemid 41775917)
6. Du, W., Adam, Z., Rani, R., Zhang, X. and Pang, Q. (2008) Oxidative stress in Fanconi anemia hematopoiesis and disease progression. Antioxid. Redox Signaling 10, 1909-1921
7. Taniguchi, T., Tischkowitz, M., Ameziane, N., Hodgson, S. V., Mathew, C. G., Joenje, H., Mok, S. C. and D'Andrea, A. D. (2003) Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. Nat. Med. 9, 568-574 (Pubitemid 36597103)
8. Ferrer, M., Izeboud, T., Ferreira, C. G., Span, S. W., Giaccone, G. and Kruyt, F. A. E. (2003) Cisplatin triggers apoptotic or nonapoptotic cell death in Fanconi anemia lymphoblasts in a concentration-dependent manner. Exp. Cell Res. 286, 381-395 (Pubitemid 36566449)
9. Boyd, J. M., Gallo, G. J., Elangovan, B., Houghton, A. B., Malstrom, S., Avery, B. J., Ebb, R. G., Subramanian, T., Chittenden, T. and Lutz, R. J. (1995) Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene 11, 1921-1928
10. Chittenden, T., Flemington, C., Houghton, A. B., Ebb, R. G., Gallo, G. J., Elangovan, B., Chinnadurai, G. and Lutz, R. J. (1995) A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. EMBO J. 14, 5589-5596
11. Chinnadurai, G., Vijayalingam, S. and Rashmi, R. (2008) BIK, the founding member of the BH3-only family proteins: mechanisms of cell death and role in cancer and pathogenic processes. Oncogene 27, S20-S29
12. Letai, A., Bassik, M. C., Walensky, L. D., Sorcinelli, M. D., Weiler, S. and Korsmeyer, S. J. (2002) Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2, 183-192 (Pubitemid 41043974)
13. McDonnell, J. M., Fushman, D., Milliman, C. L., Korsmeyer, S. J. and Cowburn, D. (1999) Solution structure of the proapoptotic molecule BID: a structural basis for apoptotic agonists and antagonists. Cell 96, 625-634 (Pubitemid 29122805)
14. Ritchie, A., Gutierrez, O. and Fernández-Luna, J. L. (2009) PAR bZIP-bik is a novel transcriptional pathway that mediates oxidative stress-induced apoptosis in fibroblasts. Cell Death Differ. 16, 838-846
15. Real, P. J., Sanz, C., Gutierrez, O., Pipaón, C., Zubiaga, A. M. and Fernandez-Luna, J. L. (2006) Transcriptional activation of the proapoptotic bik gene by E2F proteins in cancer cells. FEBS Lett. 580, 5905-5909 (Pubitemid 44584291)
16. Castells, A., Gusella, J. F., Ramesh, V. and Rustgi, A. K. (2000) A region of deletion on chromosome 22q13 is common to human breast and colorectal cancers. Cancer Res. 60, 2836-2839 (Pubitemid 30395802)
17. Li, Y. M., Wen, Y., Zhou, B. P., Kuo, H.-P., Ding, Q. and Hung, M.-C. (2003) Enhancement of Bik antitumor effect by Bik mutants. Cancer Res. 63, 7630-7633 (Pubitemid 37466686)
18. Sturm, I., Stephan, C., Gillissen, B., Siebert, R., Janz, M., Radetzki, S., Jung, K., Loening, S., Dörken, B. and Daniel, P. T. (2006) Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma. Cell Death Differ. 13, 619-627
19. Valdez, B. C., Murray, D., Ramdas, L., de Lima, M., Jones, R., Kornblau, S., Betancourt, D., Li, Y., Champlin, R. E. and Andersson, B. S. (2008) Altered gene expression in busulfan-resistant human myeloid leukemia. Leuk. Res. 32, 1684-1697
20. Bodet, L., Ménoret, E., Descamps, G., Pellat-Deceunynck, C., Bataille, R., Le Gouill, S., Moreau, P., Amiot, M. and Gomez-Bougie, P. (2010) BH3-only protein Bik is involved in both apoptosis induction and sensitivity to oxidative stress in multiple myeloma. Br. J. Cancer 103, 1808-1814
21. Spender, L. C., O'Brien, D. I., Simpson, D., Dutt, D., Gregory, C. D., Allday, M. J., Clark, L. J. and Inman, G. J. (2009) TGF-β induces apoptosis in human B-cells by transcriptional regulation of BIK and BCL-XL. Cell Death Differ. 16, 593-602
22. Jiang, A. and Clark, E. A. (2001) Involvement of Bik, a proapoptotic member of the Bcl-2 family, in surface IgM-mediated B cell apoptosis. J. Immunol. 166, 6025-6033 (Pubitemid 32440728)
23. Rathbun, R. K., Faulkner, G. R., Ostroski, M. H., Christianson, T. A., Hughes, G., Jones, G., Cahn, R., Maziarz, R., Royle, G., Keeble, W. et al. (1997) Inactivation of the Fanconi anemia group C gene augments interferon-γ-induced apoptotic responses in hematopoietic cells. Blood 90, 974-985 (Pubitemid 27314130)
24. Zhang, X., Sejas, D. P., Qiu, Y., Williams, D. A. and Pang, Q. (2007) Inflammatory ROS promote and cooperate with the Fanconi anemia mutation for hematopoietic senescence. J. Cell Sci. 120, 1572-1583 (Pubitemid 46831787)
25. Lyakhovich, A. and Surrallés, J. (2010) Constitutive activation of caspase-3 and poly ADP ribose polymerase cleavage in Fanconi anemia cells. Mol. Cancer Res. 8, 46-56
26. Maiani, E., Diederich, M. and Gonfloni, S. (2011) DNA damage response: the emerging role of c-Abl as a regulatory switch? Biochem. Pharmacol. 82, 1269-1276
27. Rathbun, R., Christianson, T., Faulkner, G., Jones, G., Keeble, W., O'Dwyer, M. and Bagby, G. (2000) Interferon-γ-induced apoptotic responses of Fanconi anemia group C hematopoietic progenitor cells involve caspase 8-dependent activation of caspase 3 family members. Blood 96, 4204-4211
28. Dai, Z., Liu, S., Marcucci, G. and Sadee, W. (2006) 5-Aza-2′- deoxycytidine and depsipeptide synergistically induce expression of BIK (BCL2-interacting killer). Biochem. Biophys. Res. Commun. 351, 455-461 (Pubitemid 44666710)
29. Haneline, L. S., Broxmeyer, H. E., Cooper, S., Hangoc, G., Carreau, M., Buchwald, M. and Clapp, D. W. (1998) Multiple inhibitory cytokines induce deregulated progenitor growth and apoptosis in hematopoietic cells from Fac-/- mice. Blood 91, 4092-4098 (Pubitemid 28261970)
30. Dufour, C., Corcione, A., Svahn, J., Haupt, R., Poggi, V., Béka'ssy, A. N., Scimè, R., Pistorio, A. and Pistoia, V. (2003) TNF-α and IFN-γ are overexpressed in the bone marrow of Fanconi anemia patients and TNF-α suppresses erythropoiesis in vitro. Blood 102, 2053-2059 (Pubitemid 37122379)
31. Ibáñez, A., Río, P., Casado, J. A., Bueren, J. A., Fernández-Luna, J. L. and Pipaón, C. (2009) Elevated levels of IL-1β in Fanconi anaemia group A patients due to a constitutively active phosphoinositide 3-kinase-Akt pathway are capable of promoting tumour cell proliferation. Biochem. J. 422, 161-170
32. Milutinovic, S., Brown, S. E., Zhuang, Q. and Szyf, M. (2004) DNA methyltransferase 1 knock down induces gene expression by a mechanism independent of DNA methylation and histone deacetylation. J. Biol. Chem. 279, 27915-27927 (Pubitemid 38900060)
33. Milutinovic, S., Zhuang, Q., Niveleau, A. and Szyf, M. (2003) Epigenomic stress response. Knockdown of DNA methyltransferase 1 triggers an intra-S-phase arrest of DNA replication and induction of stress response genes. J. Biol. Chem. 278, 14985-14995 (Pubitemid 36799830)
34. Pipaón, C., Real, P. J. and Fernandez-Luna, J. L. (2005) Defective binding of transcriptional repressor ZEB via DNA methylation contributes to increased constitutive levels of p73 in Fanconi anemia cells. FEBS Lett 579, 4610-4614 (Pubitemid 41218635)
35. Mathai, J. P., Germain, M., Marcellus, R. C. and Shore, G. C. (2002) Induction and endoplasmic reticulum location of BIK/NBK in response to apoptotic signaling by E1A and p53. Oncogene 21, 2534-2544 (Pubitemid 34438106)
36. Verma, S., Budarf, M. L., Emanuel, B. S. and Chinnadurai, G. (2000) Structural analysis of the human pro-apoptotic gene Bik: chromosomal localization, genomic organization and localization of promoter sequences. Gene 254, 157-162
37. Hur, J., Bell, D. W., Dean, K. L., Coser, K. R., Hilario, P. C., Okimoto, R. A., Tobey, E. M., Smith, S. L., Isselbacher, K. J. and Shioda, T. (2006) Regulation of expression of BIK proapoptotic protein in human breast cancer cells: p53-dependent induction of BIK mRNA by fulvestrant and proteasomal degradation of BIK protein. Cancer Res. 66, 10153-10161 (Pubitemid 44672070)
38. Tanaka, Y., Kameoka, M., Itaya, A., Ota, K. and Yoshihara, K. (2004) Regulation of HSF1-responsive gene expression by N-terminal truncated form of p73α. Biochem. Biophys. Res. Commun. 317, 865-872 (Pubitemid 38481452)
39. Brigati, C., Banelli, B., Casciano, I., Di Vinci, A., Matis, S., Cutrona, G., Forlani, A., Allemanni, G. and Romani, M. (2011) Epigenetic mechanisms regulate ΔNP73 promoter function in human tonsil B cells. Mol. Immunol. 48, 408-414